Published in Circ Cardiovasc Imaging on February 27, 2010
Study Effect of VIA-2291 on Vascular Inflammation | NCT00358826
Reactive oxygen species in cardiovascular disease. Free Radic Biol Med (2011) 2.29
Anti-inflammatory therapeutics for the treatment of atherosclerosis. Nat Rev Drug Discov (2011) 1.48
Anti-inflammatory therapies for cardiovascular disease. Eur Heart J (2014) 1.28
Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2. J Lipid Res (2012) 1.28
Inflammation, oxidative stress and renin angiotensin system in atherosclerosis. World J Biol Chem (2015) 0.99
Reproducibility of computed tomography angiography data analysis using semiautomated plaque quantification software: implications for the design of longitudinal studies. Int J Cardiovasc Imaging (2012) 0.96
Angiopoietin-like 2 promotes atherogenesis in mice. J Am Heart Assoc (2013) 0.93
Structure and ligand based drug design strategies in the development of novel 5- LOX inhibitors. Curr Med Chem (2012) 0.90
Leukotrienes in atherosclerosis: new target insights and future therapy perspectives. Mediators Inflamm (2010) 0.90
Noninvasive Imaging of Atherosclerotic Plaque Progression: Status of Coronary Computed Tomography Angiography. Circ Cardiovasc Imaging (2015) 0.86
Leukotrienes as modifiers of preclinical atherosclerosis? ScientificWorldJournal (2012) 0.84
Coronary flow reserve from mouse to man--from mechanistic understanding to future interventions. J Cardiovasc Transl Res (2013) 0.84
The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field. Eur J Clin Pharmacol (2017) 0.78
Blinding the monocytes to protect the heart. Circulation (2013) 0.76
Elucidation of the molecular mechanism and the efficacy in vivo of a novel 1,4-benzoquinone that inhibits 5-lipoxygenase. Br J Pharmacol (2014) 0.76
Interaction between allergic asthma and atherosclerosis. Transl Res (2015) 0.75
Computed tomography coronary plaque imaging as a secondary end point for randomized pharmaceutical trials: more bang for the buck? Circ Cardiovasc Imaging (2010) 0.75
Local Inhibition of Macrophage and Smooth Muscle Cell Proliferation to Suppress Plaque Progression. Methodist Debakey Cardiovasc J (2016) 0.75
Dynamic imaging of T cell-dendritic cell interactions in lymph nodes. Science (2002) 5.61
Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med (2013) 4.62
Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. JAMA (2007) 3.12
Factors predisposing to coma and delirium: fentanyl and midazolam exposure; CYP3A5, ABCB1, and ABCG2 genetic polymorphisms; and inflammatory factors. Crit Care Med (2013) 2.31
STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem (2002) 2.28
A high-fat diet impairs liver regeneration in C57BL/6 mice through overexpression of the NF-kappaB inhibitor, IkappaBalpha. Hepatology (2005) 2.18
Postinfarction ventricular septal defects: towards a new treatment algorithm? Ann Thorac Surg (2009) 2.14
Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression. Circulation (2007) 1.88
The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy. Diabetes (2006) 1.80
The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care. Can J Cardiol (2011) 1.78
Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial. J Am Coll Cardiol (2013) 1.70
Subsyndromal delirium in the ICU: evidence for a disease spectrum. Intensive Care Med (2007) 1.66
Identification of acyl coenzyme A:monoacylglycerol acyltransferase 3, an intestinal specific enzyme implicated in dietary fat absorption. J Biol Chem (2003) 1.57
Impact of previous percutaneous transluminal coronary angioplasty and/or stenting revascularization on outcomes after surgical revascularization: insights from the imagine study. Eur Heart J (2008) 1.55
Effect of pericardial blood processing on postoperative inflammation and the complement pathways. Ann Thorac Surg (2008) 1.53
Effects of anesthetic induction in patients with diastolic dysfunction. Can J Anaesth (2009) 1.50
Anti-inflammatory therapeutics for the treatment of atherosclerosis. Nat Rev Drug Discov (2011) 1.48
Percutaneous closure of secundum atrial septal defect in adults a single center experience with the amplatzer septal occluder. J Invasive Cardiol (2003) 1.48
Individual delirium symptoms: do they matter? Crit Care Med (2007) 1.47
Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions. Circulation (2004) 1.45
The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure. Can J Cardiol (2012) 1.44
Statin treatment equalizes long-term survival between patients with single and bilateral internal thoracic artery grafts. Ann Thorac Surg (2009) 1.42
Differential 1-year clinical outcomes for ST-segment elevation myocardial infarction related to stent thrombosis or saphenous vein graft thrombosis. Catheter Cardiovasc Interv (2013) 1.38
Cardiac masses: an integrative approach using echocardiography and other imaging modalities. Heart (2011) 1.29
Delays to reperfusion therapy in acute ST-segment elevation myocardial infarction: results from the AMI-QUEBEC Study. CMAJ (2006) 1.27
Answer to case of the month #106. Pelvic Digit. Can Assoc Radiol J (2006) 1.24
Extremes of clinical and enzymatic phenotypes in children with hyperinsulinism caused by glucokinase activating mutations. Diabetes (2009) 1.23
Interleukin-6 from intrahepatic cells of bone marrow origin is required for normal murine liver regeneration. Hepatology (2002) 1.23
From clinicogenetic studies of maturity-onset diabetes of the young to unraveling complex mechanisms of glucokinase regulation. Diabetes (2006) 1.20
Matrix metalloproteinase-activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicity. Mol Cancer Ther (2005) 1.20
Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice. J Clin Invest (2003) 1.13
Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. EuroIntervention (2016) 1.11
Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young. J Biol Chem (2005) 1.11
Intestinal cholesterol transport proteins: an update and beyond. Curr Opin Lipidol (2007) 1.09
Fontan circulation: success or failure? Can J Cardiol (2013) 1.06
Inhibition of tumor necrosis factor-alpha-converting enzyme by a selective antagonist protects brain from focal ischemic injury in rats. Mol Pharmacol (2004) 1.06
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol (2009) 1.04
Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-beta signals during liver regeneration. J Biol Chem (2002) 1.04
Imaging biomarkers in atherosclerosis trials. Circ Cardiovasc Imaging (2011) 1.02
Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support. Clin Sci (Lond) (2006) 1.00
Iyengar yoga for young adults with rheumatoid arthritis: results from a mixed-methods pilot study. J Pain Symptom Manage (2010) 1.00
Comparison of surgical and transcatheter treatment for native coarctation of the aorta in patients > or = 1 year old. The Quebec Native Coarctation of the Aorta study. Am Heart J (2007) 0.97
Sugar binding to recombinant wild-type and mutant glucokinase monitored by kinetic measurement and tryptophan fluorescence. Biochem J (2008) 0.97
Digoxin and reduction of heart failure hospitalization in chronic systolic and diastolic heart failure. Am J Cardiol (2008) 0.96
Pulmonary arterial hypertension in patients with transcatheter closure of secundum atrial septal defects: a longitudinal study. Circ Cardiovasc Interv (2009) 0.95
Considerable differences in vaccine immunogenicities and efficacies related to the diluent used for aluminum hydroxide adjuvant. Clin Vaccine Immunol (2008) 0.95
Transcatheter aortic valve implantation: a Canadian Cardiovascular Society position statement. Can J Cardiol (2012) 0.93
Simultaneous MR arteriography and venography with blood pool contrast agent detects deep venous thrombosis in suspected arterial disease. AJR Am J Roentgenol (2012) 0.93
A glucose sensor role for glucokinase in anterior pituitary cells. Diabetes (2006) 0.93
Management of patients with refractory angina: Canadian Cardiovascular Society/Canadian Pain Society joint guidelines. Can J Cardiol (2012) 0.91
Imaging features of constrictive pericarditis: beyond pericardial thickening. Can Assoc Radiol J (2009) 0.91
Transfusion rate for 500 consecutive liver transplantations: experience of one liver transplantation center. Transplantation (2012) 0.91
A randomized controlled, phase 2 trial of the viral serpin Serp-1 in patients with acute coronary syndromes undergoing percutaneous coronary intervention. Circ Cardiovasc Interv (2010) 0.90
Risk stratification in surgically repaired tetralogy of Fallot. Expert Rev Cardiovasc Ther (2009) 0.89
Receptor occupancy of nonpeptide corticotropin-releasing factor 1 antagonist DMP696: correlation with drug exposure and anxiolytic efficacy. J Pharmacol Exp Ther (2003) 0.88
Role of rheolytic thrombectomy in massive pulmonary embolism with contraindication to systemic thrombolytic therapy. EuroIntervention (2010) 0.88
Successful thrombolysis of a stroke with a pulmonary embolism in a young woman. J Emerg Med (2009) 0.88
Exposure to extreme cold lowers the ischemic threshold in coronary artery disease patients. Can J Cardiol (2010) 0.87
The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodies. J Rheumatol (2003) 0.87
Recanalization of systemic venous baffles by radiofrequency perforation and stent implantation. Catheter Cardiovasc Interv (2007) 0.87
Successful early percutaneous closure of acute ventricular septal rupture complicating acute myocardial infarction with Amplatzer ventricular septal occluder. Cardiol J (2007) 0.86
Clopidogrel 600-mg double loading dose achieves stronger platelet inhibition than conventional regimens: results from the PREPAIR randomized study. J Am Coll Cardiol (2008) 0.86
Effect on bleeding, time to revascularization, and one-year clinical outcomes of the radial approach during primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Am J Cardiol (2010) 0.85
Evaluation of adult congenital heart disease by cardiac magnetic resonance imaging. Congenit Heart Dis (2009) 0.84
Clinical assessment of arrhythmias in tetralogy of Fallot. Expert Rev Cardiovasc Ther (2010) 0.84
Effectiveness and safety of glycoprotein IIb/IIIa inhibitors in patients with myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of observational studies. Int J Cardiol (2010) 0.84
Images in cardiovascular medicine. Left ventricular pseudoaneurysm: a late complication of low-energy DC ablation. Circulation (2006) 0.84
Transcatheter closure of perimembranous ventricular septal defects: initial human experience with the Amplatzer® membranous VSD occluder 2. Catheter Cardiovasc Interv (2013) 0.84
Effects of the antioxidant succinobucol (AGI-1067) on human atherosclerosis in a randomized clinical trial. Atherosclerosis (2007) 0.83
A single bout of high-intensity interval exercise does not increase endothelial or platelet microparticles in stable, physically fit men with coronary heart disease. Can J Cardiol (2013) 0.82
Transcatheter mitral and pulmonary valve therapy. J Am Coll Cardiol (2009) 0.82
Disconnection between the early onset anorectic effects by C75 and hypothalamic fatty acid synthase inhibition in rodents. Eur J Pharmacol (2005) 0.82
Remodeling is a more important determinant of lumen size than atheroma burden in left main coronary artery disease. Am Heart J (2010) 0.82
Cardiac computed tomography follow-up of left atrial appendage exclusion using the Amplatzer Cardiac Plug device. Can J Cardiol (2011) 0.82
Molecular imaging of the human pulmonary vascular endothelium using an adrenomedullin receptor ligand. Mol Imaging (2015) 0.82
Effect of atherosclerotic regression on total luminal size of coronary arteries as determined by intravascular ultrasound. Am J Cardiol (2006) 0.82
Sociodemographic factors in a pediatric chronic pain clinic: The roles of age, sex and minority status in pain and health characteristics. J Pain Manag (2010) 0.82
Hybrid treatment of a complex aortic arch aneurysm with an aberrant left vertebral artery. J Card Surg (2013) 0.81
Reproducibility of abdominal aortic aneurysm diameter measurement and growth evaluation on axial and multiplanar computed tomography reformations. Cardiovasc Intervent Radiol (2011) 0.81
Canada Acute Coronary Syndrome Risk Score: a new risk score for early prognostication in acute coronary syndromes. Am Heart J (2013) 0.81
The endovascular coronary sinus catheter in minimally invasive mitral and tricuspid valve surgery: a case series. J Cardiothorac Vasc Anesth (2010) 0.80
Acute effects of statin therapy on coronary atherosclerosis following an acute coronary syndrome. Am J Cardiol (2009) 0.80
Atherosclerosis imaging and the Canadian Atherosclerosis Imaging Network. Can J Cardiol (2012) 0.79
Extensive radiation-induced heart disease in an adult patient treated for lymphoma as a child. Can J Cardiol (2011) 0.79
Concordance between an electroanatomic mapping system and cardiac MRI in arrhythmogenic right ventricular cardiomyopathy. Pacing Clin Electrophysiol (2006) 0.79